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the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction The clinical manifestations of classical MSUD are mostly neuro-Maple syrup urine disease (MSUD) is an autosomal recessive
disorder caused by a defect in any of the subunits of the mitochon-
drial branched-chain alfa ketoacid dehydrogenase (BCKAD). The
metabolic defect results in accumulation of branched-chain amino
acids (BCAAs) (leucine, isoleucine and valine) and their keto
acids [1].
Amino acids are key nutrient molecules essential for cell
growth, survival, and normal function. In addition to providing
building blocks for protein synthesis, many amino acids are essen-
tial ingredients for biosynthesis of other molecules as the source of
nitrogen and carbon [2]. Some amino acids, including branched-
chain amino acids, also have been shown to possess a potent
signaling function to regulate global growth and metabolism [3].
Therefore, the impact of amino acid metabolism on embryonic
development and human congenital diseases has long been recog-
nized [4].pathic, including seizures and mental retardation [5]. However,
recent studies from animal models of MSUD raise concerns about
the potential adverse impact of branched –chain amino acid
metabolic defects on cardiac development and function [4].2. Subjects and methods
This cross-sectional descriptive study involved 54 children with
MSUD who were recruited from the Genetics clinic, Pediatric
Hospital, Ain Shams University. Their ages ranged from 1 month
to 7.5 years with a mean of (26.7 months ± 21.5). Informed consent
was obtained from guardians of all examined cases before partici-
pation in the study which was approved by the Institutional Ethical
Review Board.
The diagnosis of MSUD was confirmed in all patients by high
serum levels of leucine, isoleucine, valine, elevated leucine/alanine
ratio and leucine/phenylalanine ratio by Tandem mass spectrome-
try (LC-MS/MS). All patients were subjected to history taking and
clinical evaluation for cardiac symptoms and signs. The work has
been carried out in accordance with The Code of Ethics of the
World Medical Association (Declaration of Helsinki) for experi-
ments in humans.
A standard two-dimensional (2D), M-mode, color flow (CF),
continuous wave (CW) and pulsed wave (PW) Doppler echocardio-
graphy was performed for patients using the segmental sequential
approach [6]. Views included subcostal view (short axis, four
chamber and coronal), parasternal view (long axis and short axis),
Table 1








Secundum atrial septal defect 4 7.4
Mitral valve prolapsed and
regurgitation
2 3.7
Pulmonary valve stenosis 1 1.9
Bilateral branch pulmonary stenosis 1 1.9
Total 25 46.3
Total 54 100
Fig. 1. 2D and color flow Doppler echocardiography showing thic
38 A.A. Kotby et al. / The Egyptian Journal of Medical Human Genetics 19 (2018) 37–41apical view (four chambers and five chambers) and suprasternal
view (short axis and long axis). Echocardiography was done using
the Vivid E9 machine (GE Vingmed Ultrasound, Horton, Norway)
and pediatric multiplane ultrasound probe with a frequency rang-
ing from 1.5 to 4.5 MHz and a 120- degree field of view (M5S-D,S/N
000002891,Portugal).
The anatomy was described in details including the situs of the
heart, atrio-ventricular concordance, and relation of the great ves-
sels, interatrial and interventricular septae, pulmonary and sys-
temic venous drainage, morphology and excursion of cardiac
valves, cardiac chamber sizes and ventricular function. The study
included the description of the aortic arch anatomy, anatomy of
the great vessels, the presence of PDA and measurement of the pul-
monary artery pressure. The presence of patent foramen ovale
(PFO) was considered normal finding.kened prolapsed regurgitating mitral valve in patient No. 41.
Fig. 2. 2D and color flow Doppler echocardiography showing fenestrated interatrial septum in patient No. 22.
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Statistical analysis was done using SPSS program version 17.
Qualitative data is presented as number and percentage and quan-
titative data is presented as mean ± standard deviation.4. Results
Twenty-five (46.3%) MSUD patients had cardiac affection.
Twenty-one of the affected patients (84%) had defects related tothe interatrial septum in the form of fenestrated thickened
interatrial septum (17,68%) and secundum type atrial septal defect
(ASD) (4, 16%). Abnormal echocardiographic findings among MSUD
patients are shown in Table 1 and Figs. 1 and 2.5. Discussion
Due to the overwhelming neurological manifestations of MSUD,
little emphasis has been given to the prenatal or postnatal involve-
ment of other organs that are involved in the metabolism of BCAA
40 A.A. Kotby et al. / The Egyptian Journal of Medical Human Genetics 19 (2018) 37–41despite the fact that most of the BCAAs are transaminated outside
the nervous system in the liver, muscles, and heart [7]. It has been
shown that skeletal muscles of newborn patients with MSUD show
focal diffuse destruction of myofibrils with evidence that the
increased levels of amino acids were not the cause [8]. Recent stud-
ies have shown that the impaired branched-chain alpha keto acid-
dehydrogenase complex (BCKD) function can be pathologic to the
heart[9].
The prenatal occurrence of such early anomalies denotes that
the pathological effect of the disease on the growing embryonic
cardiac muscle cells could not be compensated by the maternal
degradation of excess BCAA/BCKA. It is known that BCAA/BCKA
can inhibit pyruvate and fatty acid transport and utilization [10].
The BCKD complex is genetically linked with the pyruvate dehy-
drogenase complex (PDH) because they share extensive homology
in their subunit composition and regulation [4].
The underlying mechanisms for the clinical manifestations of
MSUD are still not well established, but the adverse impact on glu-
tamine transport and the induction of reactive –oxygen species
(ROS) have been implicated [11]. Recently, Sun et al., 2011 [4] have
established that a mitochondrial targeted 2C-type ser/thr protein
phosphatase, PP2Cm, is the endogenous phosphatase of the (BCKD)
and functions as a key regulator in branched-chain amino acid cat-
abolism and homeostasis. They found that genetic inactivation of
PP2Cm in mice leads to significant elevation in plasma concentra-
tions of BCAAs and BCKAs at levels similar to those associated with
intermediate mild forms of MSUD. In addition to neuronal tissues,
PP2Cmwas found to be highly expressed in the cardiac muscle and
its expression is diminished in hearts under pathologic stresses
and thus, defects in PP2Cm-mediated catabolism of branched –
chain amino acids can be a potential novel mechanism not only
for MSUD but also for CHD and heart failure.
Furthermore, it has also been found that fibroblasts from
patients with MSUD tend to accumulate damage in mitochondrial
DNA (mtDNA) as well as nuclear DNA with a corresponding reduc-
tion in mitochondrial transcription, mtDNA copy number and
pyruvate dehydrogenase[12]. Recent studies have shown that
CHDs are commonly associated with a mutation in mtDNA in 9
out of 22 patients with CHD undergoing cardiac surgery [13]. The
above studies point to the possibility of derangement of mitochon-
drial metabolism during cardiac muscle development leading to
the higher frequency of CHD among MSUD patients.
To the best of our knowledge, there has been no information
regarding the prevalence of CHD among patients with MSUD. How-
ever, few reports of autopsies of deceased patients with MSUD
showed cardiac enlargement or congestion [14–16]. Also, a case
report of CHD in a patient with MSUD was reported by Fukutomi
et al., 1993 [17] in a 2-year old Japanese girl with tetralogy of Fallot
who had undergone intracardiac repair in 1989.
In this study, (46.3%) of the MSUD patients had cardiac involve-
ment. Among the affected children, defects related to the intera-
trial septum were the commonest (84%) in the form of
fenestrated thickened interatrial septum (68%) and secundum type
ASD (16%). The remaining encountered findings included prolapsed
mitral valve leaflets with valve regurgitation (8%), branch pul-
monary artery stenosis (4%), and pulmonary valve stenosis (4%).
Unfortunately, there is no reliable data on the prevalence of
CHD among Egyptian children due to lack of computer records in
most of the hospitals, lack of congenital malformation registry,
defective registration of the cause of death, poor coordination
between cardiac outpatient clinics at ministry hospitals and pedi-
atric clinics at the private sector; in addition to the absence of
autopsy procedures to detect the incidence of CHD among the still-
born [18].Atrial septal defects constitute 8–13% of all CHDs. These types of
defects probably occur as a result of programmed cell death in par-
ticular areas of the septum primum during embryogenesis [19]
Pathologically, there is deficiency of the septal tissue in the region
of fossa ovalis. Most of the time, these are single defects, although,
occasionally multiple defects and fenestrated defects can also be
seen in a frequency around 7% [19,20]. In this study, defects related
to the interatrial septumwere the commonest encountered cardiac
abnormality as they were detected in 84% of the affected children.
This is in contrast to an Egyptian study done by Bassili et al., 2000
[18] who detected ASDs in 13.6% of 881 school children in Alexan-
dria with a prevalence of (1.4/10,000). This difference could be
attributed to the differences in the ages and the nature of the stud-
ied population in both studies as they included older aged school
children who were not suffering from any underlying genetic dis-
eases. We believe that it would be more accurate to compare our
results with other studies that include children belonging to the
same or closer geographical distribution as the relative frequencies
of CHD categories differ significantly among different regions [21].
Up to our knowledge there were no previous studies done to
screen CHD among MSUD patients of any nationality, so we were
not able to compare our results with similar studies and this sup-
ports the novelty of our study.
Although none of our patients show any signs of cardiac decom-
pensation, those defects may worsen the outcome during the fre-
quent metabolic crises that occur in the course of the disease.
We suggest that echocardiographic screening of neonates and
patients with MSUD should be done to detect possible CHD and
anticipate cardiac complications during severe illness.
6. Study limitations
This study is a pilot study that only highlights the importance of
screening patients with MSUD for cardiac defects; yet whether the
presence of cardiac involvement is a sequelae of the genetic dis-
ease or only a concomitant association still needs to be thoroughly
investigated by studying the risk factors known to increase the
incidence of CHD and by comparing findings among different types
of MSUD.
7. Conclusion
Interatrial defects among other congenital heart defects have
been found to be a frequent finding in patients with MSUD. There-
fore, routine screening of MSUD patients by echocardiography is
recommended in all cases with MSUD to detect silent cardiac
anomalies that may worsen the clinical outcome.
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